Portfolio Investment (CPIS)
Portfolio investments include investments in equity and investment fund shares, where the investor's share is less than 10%, as well as debt securities investment. The data on the portfolio investment stock on the assets side are presented crosswise according to: the country of investment and the type of the security, the country of investment and the sector of the domestic investor, and the type of the security and the original currency in which the securities are issued.
Foreign securities investments already included in the official foreign reserves data are not included in the portfolio investments category.
Latest developments:
On 30.06.2023, portfolio investment stock on the assets side (investments of residents in foreign securities) amounted to Euro 778.8 million, of which Euro 690.2 million are investments in foreign equity securities, while Euro 88.6 million are investments in foreign debt securities.
Analyzed by countries, the largest portfolio investments are in the United States, in the amount of Euro 565 million, Germany, in the amount of Euro 87.2 million and France, amounting Euro 33 million.
From the aspect of the investments by the currency of denomination, the largest part of portfolio investments are made in US Dollar and Euro (Euro 616.2 million and Euro 139.7 million, respectively).
Analyzed by the Sector of the resident holder, at the end of first semester of 2023, Insurance Corporations and Pensions Funds have a dominant share, with stock of portfolio investments amounted to Euro 622.1 million or 79.9% from the total portfolio investments.
With respect to the Sector of the non-resident issuer, resident investments in securities issued by Other Financial Corporations (other than Insurance Corporations and Pension Funds and Money Market Funds) and Nonfinancial Corporations (Euro 533.9 million and Euro 133.8 million, respectively) are dominant.
Archive on Portfolio Investment (CPIS)
For more detailed information on the released statistical data, please contact us at [email protected] or+389 2 3215 181 ext.103 (or 110/108)